Research suggests that intranasal nanosuspensions offer a promising way to formulate and deliver drugs that are poorly soluble in water to patients with chronic conditions.
Rajeev Singh Raghuvanshi, PhD
Advertisement
Rajeev Singh Raghuvanshi, PhD, is senior vice president at Dr. Reddy’s Laboratories Ltd
Articles by Rajeev Singh Raghuvanshi, PhD
Advertisement
Latest Updated Articles
Assessment of Nanosuspension Formulation for Intranasal AdministrationPublished: September 3rd 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
3
Challenges for the Global Manufacturing of Vaccines
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
